Mladsi D, Zhou X, Mader G, Sanon M, Wang J, Barnett C, Willey C, Seliger S. Mortality risk in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2024 Feb 16;25(1):56. doi: 10.1186/s12882-024-03484-3
Danese D, Goss D, Romano (DeMuro) C, Gupta C. Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study. BMC Nephrol. 2023 Oct 26;24(1):319. doi: 10.1186/s12882-023-03365-1
Khairat S, Chourasia P, Kwong E, Choi JM, Seashore C. Effect of tailored coaching on physicians' electronic health record proficiency and user experience: a randomized crossover study. May Clin Proc Digital Health. 2023 Jun;1(2):94-104. doi: 10.1016/j.mcpdig.2023.02.005
Mader G, Mladsi D, Sanon M, Purser M, Barnett CL, Oberdhan D, Watnick T, Seliger S. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrol. 2022 Oct 18;23(1):334. doi: 10.1186/s12882-022-02956-8
Brown AL, Lupo PJ, Danysh HE, Okcu MF, Scheurer ME, Kamdar KY. Prevalence and predictors of overweight and obesity among a multiethnic population of pediatric acute lymphoblastic leukemia survivors: a cross-sectional assessment. J Pediatr Hematol Oncol. 2016 Aug;38(6):429-36. doi: 10.1097/MPH.0000000000000555
Phanikumar CV, Maitra B. Valuing urban bus attributes: an experience in Kolkata. J Public Transport. 2006;9(2):69-87. doi: 10.5038/2375-0901.9.2.4
Phani Kumar CV, Basu D, Maitra B. Modeling generalized cost of travel for rural bus users: a case study. J Public Transport. 2004;7(2):59-72. doi: 10.5038/2375-0901.7.2.4
Langagergaard V, Norgard B, Mellemkjaer L, Pendersen L, Rothman KJ, Sorensen HT. Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin's disease and non-Hodgkin's lymphoma. J Pediatr Hematol Oncol. 2003 Jul;25(7):534-8.